Frances Murphy, co-head of the pharmaceuticals, biotechnology and healthcare group of Slaughter and May, has been named to head the international law firm’s flagship corporate team, effective May 1. Murphy will succeed Chris Saul, who has been named a senior partner.
Frances Murphy
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.